Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey

Creative Commons License

ÖZTÜRK S., Turgutalp K., ARICI M., Odabas A. R., ALTIPARMAK M. R., Aydin Z., ...More

NEPHROLOGY DIALYSIS TRANSPLANTATION, vol.35, no.12, pp.2083-2095, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 12
  • Publication Date: 2020
  • Doi Number: 10.1093/ndt/gfaa271
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.2083-2095
  • Keywords: COVID-19, haemodialysis, kidney disease, mortality, renal transplantation, REPLACEMENT, POPULATION, RISK
  • Çanakkale Onsekiz Mart University Affiliated: Yes


Background. Chronic kidney disease (CKD) and immunosuppression, such as in renal transplantation (RT), stand as one of the established potential risk factors for severe coronavirus disease 2019 (COVID-19). Case morbidity and mortality rates for any type of infection have always been much higher in CKD, haemodialysis (HD) and RT patients than in the general population. A large study comparing COVID-19 outcome in moderate to advanced CKD (Stages 3-5), HD and RT patients with a control group of patients is still lacking.